atenolol has been researched along with Retrolental Fibroplasia in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martini, D | 1 |
| Monte, MD | 1 |
| Ristori, C | 1 |
| Cupisti, E | 1 |
| Mei, S | 1 |
| Fiorini, P | 1 |
| Filippi, L | 1 |
| Bagnoli, P | 1 |
1 other study available for atenolol and Retrolental Fibroplasia
| Article | Year |
|---|---|
Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Animal | 2011 |